MICRON TECHNOLOGY, INC. |
(Exact name of registrant as specified in its charter) |
Delaware | 1-10658 | 75-1618004 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
8000 South Federal Way |
Boise, Idaho 83716-9632 |
(Address of principal executive offices) |
(208) 368-4000 |
(Registrant’s telephone number, including area code) |
Item 2.02. | Results of Operations and Financial Condition. |
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits. |
Exhibit No. | Description | |
99.1 |
MICRON TECHNOLOGY, INC. | |||
Date: | June 20, 2018 | By: | /s/ David A. Zinsner |
Name: | David A. Zinsner | ||
Title: | Senior Vice President and Chief Financial Officer |
Contacts: | Shanye Hudson | David Oro |
Investor Relations | Media Relations | |
shudson@micron.com | davidoro@micron.com | |
(208) 492-1205 | (707) 558-8585 |
• | Operating cash flow of $4.26 billion, compared with $2.41 billion for the same period last year |
• | Ended the quarter with a net cash positive position |
Quarterly Financial Results | |||||||||||||||||||||||||||||||
(in millions except per share amounts) | GAAP (1) | Non-GAAP (2) | |||||||||||||||||||||||||||||
FQ3-18 | FQ2-18 | FQ3-17 | FQ3-18 | FQ2-18 | FQ3-17 | ||||||||||||||||||||||||||
Net sales | $ | 7,797 | $ | 7,351 | $ | 5,566 | $ | 7,797 | $ | 7,351 | $ | 5,566 | |||||||||||||||||||
Gross margin | $ | 4,723 | $ | 4,270 | $ | 2,609 | $ | 4,750 | $ | 4,296 | $ | 2,671 | |||||||||||||||||||
percent of net sales | 60.6 | % | 58.1 | % | 46.9 | % | 60.9 | % | 58.4 | % | 48.0 | % | |||||||||||||||||||
Operating income | $ | 3,953 | $ | 3,567 | $ | 1,963 | $ | 4,017 | $ | 3,630 | $ | 2,071 | |||||||||||||||||||
percent of net sales | 50.7 | % | 48.5 | % | 35.3 | % | 51.5 | % | 49.4 | % | 37.2 | % | |||||||||||||||||||
Net income attributable to Micron | $ | 3,823 | $ | 3,309 | $ | 1,647 | $ | 3,898 | $ | 3,495 | $ | 1,896 | |||||||||||||||||||
Diluted earnings per share | $ | 3.10 | $ | 2.67 | $ | 1.40 | $ | 3.15 | $ | 2.82 | $ | 1.62 |
3rd Qtr. | 2nd Qtr. | 3rd Qtr. | Nine Months Ended | ||||||||||||||||
May 31, 2018 | March 1, 2018 | June 1, 2017 | May 31, 2018 | June 1, 2017 | |||||||||||||||
Net sales | $ | 7,797 | $ | 7,351 | $ | 5,566 | $ | 21,951 | $ | 14,184 | |||||||||
Cost of goods sold | 3,074 | 3,081 | 2,957 | 9,211 | 8,860 | ||||||||||||||
Gross margin | 4,723 | 4,270 | 2,609 | 12,740 | 5,324 | ||||||||||||||
Selling, general, and administrative | 211 | 196 | 204 | 598 | 550 | ||||||||||||||
Research and development | 603 | 523 | 434 | 1,574 | 1,377 | ||||||||||||||
Other operating (income) expense, net | (44 | ) | (16 | ) | 8 | (49 | ) | 31 | |||||||||||
Operating income | 3,953 | 3,567 | 1,963 | 10,617 | 3,366 | ||||||||||||||
Interest income (expense), net (1) | (44 | ) | (61 | ) | (143 | ) | (206 | ) | (428 | ) | |||||||||
Other non-operating income (expense), net (1) | (193 | ) | (53 | ) | (83 | ) | (450 | ) | (63 | ) | |||||||||
Income tax (provision) benefit (2) | 109 | (143 | ) | (92 | ) | (148 | ) | (161 | ) | ||||||||||
Equity in net income (loss) of equity method investees | (2 | ) | 1 | 2 | (1 | ) | 7 | ||||||||||||
Net (income) attributable to noncontrolling interests | — | (2 | ) | — | (2 | ) | — | ||||||||||||
Net income attributable to Micron | $ | 3,823 | $ | 3,309 | $ | 1,647 | $ | 9,810 | $ | 2,721 | |||||||||
Earnings per share | |||||||||||||||||||
Basic | $ | 3.30 | $ | 2.86 | $ | 1.49 | $ | 8.53 | $ | 2.52 | |||||||||
Diluted | 3.10 | 2.67 | 1.40 | 7.96 | 2.38 | ||||||||||||||
Number of shares used in per share calculations | |||||||||||||||||||
Basic | 1,159 | 1,156 | 1,106 | 1,150 | 1,082 | ||||||||||||||
Diluted | 1,235 | 1,238 | 1,177 | 1,233 | 1,142 |
As of | May 31, 2018 | March 1, 2018 | August 31, 2017 | |||||||||
Cash and short-term investments | $ | 7,071 | $ | 8,042 | $ | 5,428 | ||||||
Receivables | 4,912 | 4,437 | 3,759 | |||||||||
Inventories | 3,369 | 3,184 | 3,123 | |||||||||
Total current assets | 15,499 | 15,836 | 12,457 | |||||||||
Long-term marketable investments | 487 | 520 | 617 | |||||||||
Property, plant, and equipment, net | 22,705 | 21,864 | 19,431 | |||||||||
Restricted cash | 119 | 113 | 107 | |||||||||
Total assets | 41,845 | 41,263 | 35,336 | |||||||||
Accounts payable and accrued expenses | 3,998 | 4,194 | 3,664 | |||||||||
Current debt (1) | 1,454 | 1,514 | 1,262 | |||||||||
Total current liabilities | 5,883 | 6,135 | 5,334 | |||||||||
Long-term debt (1) | 5,890 | 7,802 | 9,872 | |||||||||
Total Micron shareholders' equity (3) | 28,649 | 25,697 | 18,621 | |||||||||
Noncontrolling interests in subsidiaries | 869 | 869 | 849 | |||||||||
Total equity | 29,518 | 26,566 | 19,470 |
Nine Months Ended | ||||||||
May 31, 2018 | June 1, 2017 | |||||||
Net cash provided by operating activities (a) | $ | 12,245 | $ | 4,950 | ||||
Net cash provided by (used for) investing activities (a) | (6,087 | ) | (6,259 | ) | ||||
Net cash provided by (used for) financing activities | (4,443 | ) | 1,207 | |||||
Depreciation and amortization | 3,552 | 2,888 | ||||||
Investments in capital expenditures | (6,798 | ) | (3,730 | ) | ||||
Acquisition of Inotera | — | (2,634 | ) | |||||
Repayments of debt | (6,767 | ) | (1,774 | ) | ||||
Proceeds from issuance of stock | 1,636 | 108 | ||||||
Proceeds from issuance of debt | 969 | 3,136 |
(1) | In the third quarter of 2018, we prepaid debt with an aggregate principal amount of $2.08 billion for cash of $2.11 billion and recognized non-operating losses of $42 million. We repurchased or settled convertible notes with an aggregate principal amount of $228 million for cash of $1.11 billion and recognized non-operating losses of $32 million. Additionally, as of May 31, 2018, $101 million of aggregate principal amount of our convertible notes had converted but will not settle until the fourth quarter of 2018. As a result of the unsettled conversions, the carrying values increased by $456 million as of May 31, 2018 and we recognized non-operating losses of $94 million in the third quarter of 2018. In the second quarter of 2018, we settled convertible notes with an aggregate principal amount of $65 million for cash of $295 million. In the first quarter of 2018, we redeemed notes with an aggregate principal amount of $2.25 billion for cash of $2.42 billion and recognized non-operating losses of $190 million. |
(2) | On December 22, 2017, the United States enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the "Tax Act") that lowers the U.S. corporate income tax rate from 35% to 21% and significantly affects how income from foreign operations is taxed in the United States. As a result of our fiscal year-end, our U.S. statutory federal rate will be 25.7% for 2018 (based on the 35% corporate rate through December 31, 2017 and 21% from that date through the end of fiscal year 2018) and 21% for subsequent years. The Tax Act imposes a one-time transition tax in 2018 on the higher of our accumulated foreign income, as determined as of November 2, 2017 or December 31, 2017 (the "Repatriation Tax"); provides a U.S. federal tax exemption on foreign earnings distributed to the United States; and, beginning in 2019, creates a new minimum tax on certain foreign earnings in excess of a deemed return on tangible assets (the "Foreign Minimum Tax"). The Tax Act allows us to elect to pay any Repatriation Tax due in eight annual interest-free payments in increasing amounts beginning in December 2018. In connection with the provisions of the Tax Act, we are continuing to evaluate whether to account for the Foreign Minimum Tax provisions that begin for us in 2019 as a period cost or in our measurement of deferred taxes. |
3rd Qtr. | 2nd Qtr. | 3rd Qtr. | Nine Months Ended | ||||||||||||||||
May 31, 2018 | March 1, 2018 | June 1, 2017 | May 31, 2018 | June 1, 2017 | |||||||||||||||
Provisional estimate for the Repatriation Tax, net of adjustments related to uncertain tax positions | $ | 222 | $ | (1,335 | ) | $ | — | $ | (1,113 | ) | $ | — | |||||||
Remeasurement of deferred tax assets and liabilities reflecting the lower U.S. corporate tax rates | — | (133 | ) | — | (133 | ) | — | ||||||||||||
Provisional estimate for the release of the valuation allowance on the net deferred tax assets of our U.S. operations | — | 1,337 | — | 1,337 | — | ||||||||||||||
Utilization of and other changes in net deferred tax assets of MMJ, MMT, and MTTW | (35 | ) | (17 | ) | (31 | ) | (78 | ) | (52 | ) | |||||||||
Other income tax (provision) benefit | (78 | ) | 5 | (61 | ) | (161 | ) | (109 | ) | ||||||||||
$ | 109 | $ | (143 | ) | $ | (92 | ) | $ | (148 | ) | $ | (161 | ) |
(3) | In October 2017, we issued 34 million shares of our common stock for $41.00 per share in a public offering, for proceeds of $1.36 billion, net of underwriting fees and other offering costs. |
3rd Qtr. | 2nd Qtr. | 3rd Qtr. | |||||||||||||||||||||||||||||||||||||||
May 31, 2018 | March 1, 2018 | June 1, 2017 | |||||||||||||||||||||||||||||||||||||||
GAAP | Adj | Non-GAAP | GAAP | Adj | Non-GAAP | GAAP | Adj | Non-GAAP | |||||||||||||||||||||||||||||||||
Net sales | $ | 7,797 | $ | — | $ | 7,797 | $ | 7,351 | $ | — | $ | 7,351 | $ | 5,566 | $ | — | $ | 5,566 | |||||||||||||||||||||||
Cost of goods sold | 3,074 | (27 | ) | 3,047 | 3,081 | (26 | ) | 3,055 | 2,957 | (62 | ) | 2,895 | |||||||||||||||||||||||||||||
Gross margin | 4,723 | 27 | 4,750 | 4,270 | 26 | 4,296 | 2,609 | 62 | 2,671 | ||||||||||||||||||||||||||||||||
percent of net sales | 60.6 | % | 60.9 | % | 58.1 | % | 58.4 | % | 46.9 | % | 48.0 | % | |||||||||||||||||||||||||||||
Selling, general, and administrative | 211 | (14 | ) | 197 | 196 | (16 | ) | 180 | 204 | (20 | ) | 184 | |||||||||||||||||||||||||||||
Research and development | 603 | (15 | ) | 588 | 523 | (14 | ) | 509 | 434 | (14 | ) | 420 | |||||||||||||||||||||||||||||
Other operating (income) expense, net | (44 | ) | (8 | ) | (52 | ) | (16 | ) | (7 | ) | (23 | ) | 8 | (12 | ) | (4 | ) | ||||||||||||||||||||||||
Operating expenses | 770 | (37 | ) | 733 | 703 | (37 | ) | 666 | 646 | (46 | ) | 600 | |||||||||||||||||||||||||||||
Operating income | 3,953 | 64 | 4,017 | 3,567 | 63 | 3,630 | 1,963 | 108 | 2,071 | ||||||||||||||||||||||||||||||||
percent of net sales | 50.7 | % | 51.5 | % | 48.5 | % | 49.4 | % | 35.3 | % | 37.2 | % | |||||||||||||||||||||||||||||
Interest income (expense), net | (44 | ) | 23 | (21 | ) | (61 | ) | 26 | (35 | ) | (143 | ) | 30 | (113 | ) | ||||||||||||||||||||||||||
Other non-operating income (expense), net | (193 | ) | 194 | 1 | (53 | ) | 53 | — | (83 | ) | 83 | — | |||||||||||||||||||||||||||||
3,716 | 281 | 3,997 | 3,453 | 142 | 3,595 | 1,737 | 221 | 1,958 | |||||||||||||||||||||||||||||||||
Income tax (provision) benefit | 109 | (206 | ) | (97 | ) | (143 | ) | 44 | (99 | ) | (92 | ) | 28 | (64 | ) | ||||||||||||||||||||||||||
Equity in net income (loss) of equity method investees | (2 | ) | — | (2 | ) | 1 | — | 1 | 2 | — | 2 | ||||||||||||||||||||||||||||||
Net income | 3,823 | 75 | 3,898 | 3,311 | 186 | 3,497 | 1,647 | 249 | 1,896 | ||||||||||||||||||||||||||||||||
Net income (loss) attributable to noncontrolling interests | — | — | — | (2 | ) | — | (2 | ) | — | — | — | ||||||||||||||||||||||||||||||
Net income attributable to Micron | $ | 3,823 | $ | 75 | $ | 3,898 | $ | 3,309 | $ | 186 | $ | 3,495 | $ | 1,647 | $ | 249 | $ | 1,896 | |||||||||||||||||||||||
Shares used in calculations | 1,235 | 3 | 1,238 | 1,238 | 2 | 1,240 | 1,177 | (8 | ) | 1,169 | |||||||||||||||||||||||||||||||
Diluted earnings per share | $ | 3.10 | $ | 0.05 | $ | 3.15 | $ | 2.67 | $ | 0.15 | $ | 2.82 | $ | 1.40 | $ | 0.22 | $ | 1.62 |
3rd Qtr. | 2nd Qtr. | 3rd Qtr. | |||||||||
May 31, 2018 | March 1, 2018 | June 1, 2017 | |||||||||
Non-GAAP adjustments | |||||||||||
Cost of goods sold | |||||||||||
Stock-based compensation | $ | 20 | $ | 22 | $ | 24 | |||||
Flow-through of Inotera inventory step up | — | — | 36 | ||||||||
Other | 7 | 4 | 2 | ||||||||
27 | 26 | 62 | |||||||||
Selling, general, and administrative | |||||||||||
Stock-based compensation | 14 | 16 | 20 | ||||||||
14 | 16 | 20 | |||||||||
Research and development | |||||||||||
Stock-based compensation | 14 | 14 | 13 | ||||||||
Other | 1 | — | 1 | ||||||||
15 | 14 | 14 | |||||||||
Other operating (income) expense, net | |||||||||||
Restructure and asset impairments | 8 | 7 | 12 | ||||||||
Interest income (expense), net | |||||||||||
Amortization of debt discount and other costs | 23 | 26 | 30 | ||||||||
Other non-operating income (expense) | |||||||||||
Loss on debt repurchases and conversions | 168 | 23 | 61 | ||||||||
(Gain) loss from changes in currency exchange rates | 24 | 27 | 22 | ||||||||
Other | 2 | 3 | — | ||||||||
194 | 53 | 83 | |||||||||
Income taxes | |||||||||||
Impact of U.S. income tax reform | (222 | ) | 131 | — | |||||||
Estimated tax effects of above, including tax benefits from stock-based compensation, and non-cash changes in net deferred taxes | 16 | (87 | ) | 28 | |||||||
(206 | ) | 44 | 28 | ||||||||
$ | 75 | $ | 186 | $ | 249 |
• | Stock-based compensation; |
• | Flow-through of business acquisition-related inventory adjustments; |
• | Restructure and asset impairments; |
• | Amortization of debt discount and other costs, including the accretion of non-cash interest expense associated with our convertible debt and MMJ installment debt; |
• | Losses from debt repurchases and conversions; |
• | Gains and losses from changes in currency exchange rates; |
• | Gains and losses from business acquisition activities; |
• | Impact of the U.S. income tax reform for provisional estimate of Repatriation Tax, release of U.S. valuation allowance, and remeasurement of net deferred taxes reflecting the lower U.S. corporate tax rates; and |
• | The estimated tax effects of above, including tax benefits from stock-based compensation, and non-cash changes in net deferred taxes. |